Switch to Aflibercept in the Treatment of Neovascular AMD: Long-Term Results

Switch to Aflibercept in the Treatment of Neovascular AMD: Long-Term Results

Purpose. To report the long-term clinical outcomes after switching from intravitreal bevacizumab or ranibizumab to aflibercept therapy in eyes with AMD. Methods. Retrospective analysis of changes in BCVA, SD-OCT image, and frequency of injections after 1, 2, and 3 years of follow-up. Results. 164 ey...

Full description

Saved in:
Bibliographic Details
Main Authors: Pedro Neves Cardoso, Ana Fernanda Pinheiro, Jorge Meira, Ana Catarina Pedrosa, Manuel S. Falcão, João Pinheiro-Costa, Fernando Falcão-Reis, Ângela M. Carneiro
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2017/6835782
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items